Our study provides strong in vivo evidence supporting the important roles of SMAD3 in protecting vessel wall integrity and suppressing inflammation in the pathogenesis of CaCl2-induced AAAs. The gene discussed is SMAD3; the disease is achalasia-alacrima syndrome.